Albert Bourla ( Pfizer CEO ) : Family, Net Worth, Parents, Wife, Children, Education, Salary and Nationality

Albert Bourla is a Greek veterinarian and the chairman and chief executive officer of Pfizer know all about him in this article as like his Family, Net Worth, Parents, Wife, Children, Education, Salary and Nationality

Albert Bourla ( Pfizer CEO ) : Family, Net Worth, Parents, Wife, Children, Education, Salary and Nationality
Albert Bourla Pfizer CEO
  Bio
Name Albert Bourla
Birthdate ( Age) 21 October 1961
Place of Birth Thessaloniki, Greece
Nationality Greek
Marital Status  Married
Spouse/Partner Myriam Alchanati
Children Two
Parents Name not Known
Education Aristotle University of Thessaloniki (1979–1985), Aristotle University of Thessaloniki
Profession Chief Executive Officer of Pfizer
Net Worth $30 Million
Last Update Nonember 2021

Albert Bourla is a Greek veterinarian and the chairman and chief executive officer of Pfizer, an American pharmaceutical company. He joined the company in 1993 and has held several executive roles across Pfizer's divisions. Prior to becoming chief executive officer, Bourla served as chief operating officer.

He is also credited with helping the development of Improvac, which eradicates boar taint, and for refocusing Pfizer's vaccine division to focus on staphylococcus, clostridioides difficile infection, infant diseases, and the Pfizer–BioNTech COVID-19 vaccine. He opposes government interference in pharmaceutical pricing, which he believes would hamper spending on development of new drugs.

Early Life and Family

Bourla was born and raised in Thessaloniki, Greece.His parents, who were Sephardi Jews, were among the 2,000 of 50,000 Jews in Thessaloniki to survive the Holocaust; his mother was minutes away from execution by firing squad when she was spared via a ransom paid to a Nazi Party official by her non-Jewish brother-in-law, while his father happened to be out of the Jewish ghetto when the residents were taken to the Auschwitz concentration camp and went into hiding, never to see his parents again.

Bourla earned a doctorate in the biotechnology of reproduction at Aristotle University of Thessaloniki's Veterinary School in 1985.He left Greece with his wife when he was 34 after a promotion within Pfizer and since then he has lived in seven different cities, in four different countries.

Albert Bourla Wife, Is Albert Bourla Married

Albert Bourla Married with wife Albert Bourla.The couple have two children together a Son and a Daughter.Albert Bourla live in Scarsdale, New York with his family.

Albert Bourla Net Worth and Salary

Albert Bourla is a Greek veterinarian and the chairman and chief executive officer of Pfizer, an American pharmaceutical company has an estimated Net Worth around $30 Million.He received $21 million in compensation from Pfizer in 2020.Albert Bourla owns over 53,925 units of Pfizer stock worth over $7,240,042 and over the last 8 years he sold PFE stock worth over $5,557,386. In addition, he makes $17,929,000 as Chairman of the Board and Chief Executive Officer at Pfizer.

Professional Career

Bourla joined Pfizer in 1993, first serving as a doctor of veterinary medicine and technical director for the company's animal health division in Greece.In 2001, he emigrated to the United States.He held multiple executive roles at Zoetis  and other divisions of Pfizer.From 2005 to 2009, he served as area president for Animal Health's Europe, Africa and Middle East division. In 2009 and 2010, he oversaw the Europe, Africa, and Asia Pacific division.In the latter role, he managed the merger of Wyeth's Fort Dodge Animal Health business with Pfizer in these regions.

From 2010 to 2013, Bourla served as president and general manager of Pfizer's Established Products Business Unit.There, he built business for the company's drugs that had recently lost patent exclusivity.

From January 2014 to January 2016, Bourla served as Group President of Pfizer's Global Vaccines, Oncology, and Consumer Healthcare business, where he led Pfizer's work on cancer and heart drugs, among others, and helped launch Eliquis, an anticoagulant, and Ibrance, a breast cancer treatment drug.

From February 2016 to December 2017, he was group president of Pfizer Innovative Health.In 2016, during his tenure, Innovative Health's revenue increased by 11%.Bourla became Pfizer's chief operating officer (COO) on January 1, 2018, overseeing the company's drug development, manufacturing, sales, and strategy.He restructured Pfizer and spun-off the consumer health care business during his tenure as COO.

He was promoted to chief executive officer in October 2018, effective January 1, 2019, succeeding Ian Read, his mentor.In February 2019, Bourla was one of seven CEOs in the pharmaceutical industry who participated in a hearing on prescription drug prices in the United States with the United States Senate Committee on Finance.

In April 2019, at the Prix Galien Greece Awards ceremony, he was presented with the award for "Preeminent Greek Leader" of the global pharmaceutical industry by Geoffrey R. Pyatt, United States Ambassador to Greece.In January 2020, Bourla assumed the additional post of executive chairman, upon the retirement of Ian Read.

In 2020, Bourla pushed Pfizer employees for the fast development of a COVID-19 vaccine in partnership with German company BioNTech, making sure it is safe and effective.He told his team that "financial returns should not drive any decisions" with regards to the vaccine.He took the risk of producing the Pfizer–BioNTech COVID-19 vaccine before approval from the Food and Drug Administration so that it would be ready to ship immediately upon approval.In 2020, he was ranked as America's top CEO in the pharmaceutical industry by Institutional Investor.

Check Here : Top 10 Best Car Accessories

Check Here : Top 10 Earphones in The world